ConductScience.org, home

Paper7634976

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.

Winde G and 5 others. Dis Colon Rectum, 1995. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Papers, record 7634976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7634976

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
PubMed
Journal
Dis Colon Rectum
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase II, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
2.76
iCite
Revised in PubMed
2019-07-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Winde GG
2Schmid KWK W
3Schlegel WW
4Fischer RR
5Osswald HH
6Bünte HH

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenomatous Polyposis ColiMajor topic
ColectomyMajor topic
Rectal NeoplasmsMajor topic
SulindacMajor topic
Administration, Rectal
Adolescent
Adult
Anastomosis, Surgical
Cyclins
Dinoprost
Dinoprostone
Female
Follow-Up Studies
Humans
Ki-67 Antigen
Male
Middle Aged
Neoplasm Proteins
Nuclear Proteins
Pilot Projects
Proctoscopy
Proliferating Cell Nuclear Antigen
Remission Induction

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
40451978Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies.Fam Cancer2025https://conductscience.org/library/papers/40451978PubMed
38050626Chemoprevention in hereditary digestive neoplasia: A comprehensive review.Ther Adv Gastroenterol2023https://conductscience.org/library/papers/38050626PubMed
33922305Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.Int J Mol Sci2021https://conductscience.org/library/papers/33922305PubMed
32132117Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.Cancer Prev Res (Phila)2020https://conductscience.org/library/papers/32132117PubMed
31705372Hereditary Polyposis Syndromes.Curr Treat Options Gastroenterol2019https://conductscience.org/library/papers/31705372PubMed
28786406Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.Am J Gastroenterol2017https://conductscience.org/library/papers/28786406PubMed
26109217Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.J Natl Cancer Inst2015https://conductscience.org/library/papers/26109217PubMed
25531498Chemoprevention of colorectal cancer.Dig Dis2015https://conductscience.org/library/papers/25531498PubMed
24817992Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.World J Colorectal Surg2013https://conductscience.org/library/papers/24817992PubMed
23875171COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.Front Oncol2013https://conductscience.org/library/papers/23875171PubMed
20086108Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.Cancer Epidemiol Biomarkers Prev2010https://conductscience.org/library/papers/20086108PubMed
19755659Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.Carcinogenesis2009https://conductscience.org/library/papers/19755659PubMed
19276279Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.Clin Cancer Res2009https://conductscience.org/library/papers/19276279PubMed
18193239Occurrence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction.Int J Colorectal Dis2008https://conductscience.org/library/papers/18193239PubMed
16497869
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.
J Clin Pathol2006https://conductscience.org/library/papers/16497869PubMed
14762779Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.Gastroenterology2004https://conductscience.org/library/papers/14762779PubMed
14627347Rofecoxib reduces polyp recurrence in familial polyposis.Dig Dis Sci2003https://conductscience.org/library/papers/14627347PubMed
11819418Expression of proliferating cell nuclear antigen in polyps from large intestine.World J Gastroenterol1999https://conductscience.org/library/papers/11819418PubMed
11454800Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.Gut2001https://conductscience.org/library/papers/11454800PubMed
11115827Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.Gut2001https://conductscience.org/library/papers/11115827PubMed

See all 25 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCNL281669PubTator's text mininghttps://conductscience.org/library/genes/81669NCBI Gene
PCNA5111PubTator's text mininghttps://conductscience.org/library/genes/5111NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7634976

GET https://conductscience.org/api/papers/v1/7634976/cited_by?page=2